232 related articles for article (PubMed ID: 32120837)
1. Src Inhibition Attenuates Liver Fibrosis by Preventing Hepatic Stellate Cell Activation and Decreasing Connetive Tissue Growth Factor.
Seo HY; Lee SH; Lee JH; Kang YN; Hwang JS; Park KG; Kim MK; Jang BK
Cells; 2020 Feb; 9(3):. PubMed ID: 32120837
[TBL] [Abstract][Full Text] [Related]
2. Targeting Src family kinase member Fyn by Saracatinib attenuated liver fibrosis in vitro and in vivo.
Du G; Wang J; Zhang T; Ding Q; Jia X; Zhao X; Dong J; Yang X; Lu S; Zhang C; Liu Z; Zeng Z; Safadi R; Qi R; Zhao X; Hong Z; Lu Y
Cell Death Dis; 2020 Feb; 11(2):118. PubMed ID: 32051399
[TBL] [Abstract][Full Text] [Related]
3. Proline-rich tyrosine kinase 2 mediates transforming growth factor-beta-induced hepatic stellate cell activation and liver fibrosis.
Kim J; Kang W; Kang SH; Park SH; Kim JY; Yang S; Ha SY; Paik YH
Sci Rep; 2020 Dec; 10(1):21018. PubMed ID: 33273492
[TBL] [Abstract][Full Text] [Related]
4. Fibronectin Type III Domain-Containing 5 Attenuates Liver Fibrosis Via Inhibition of Hepatic Stellate Cell Activation.
Zhou B; Ling L; Zhang F; Liu TY; Zhou H; Qi XH; Chen Q; Li YH; Kang YM; Zhu GQ
Cell Physiol Biochem; 2018; 48(1):227-236. PubMed ID: 30007970
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-β (TGF-β)-mediated connective tissue growth factor (CTGF) expression in hepatic stellate cells requires Stat3 signaling activation.
Liu Y; Liu H; Meyer C; Li J; Nadalin S; Königsrainer A; Weng H; Dooley S; Ten Dijke P
J Biol Chem; 2013 Oct; 288(42):30708-30719. PubMed ID: 24005672
[TBL] [Abstract][Full Text] [Related]
6. A novel STAT3 inhibitor, STX-0119, attenuates liver fibrosis by inactivating hepatic stellate cells in mice.
Choi S; Jung HJ; Kim MW; Kang JH; Shin D; Jang YS; Yoon YS; Oh SH
Biochem Biophys Res Commun; 2019 May; 513(1):49-55. PubMed ID: 30935693
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis
Zou GL; Zuo S; Lu S; Hu RH; Lu YY; Yang J; Deng KS; Wu YT; Mu M; Zhu JJ; Zeng JZ; Zhang BF; Wu X; Zhao XK; Li HY
World J Gastroenterol; 2019 Aug; 25(30):4222-4234. PubMed ID: 31435175
[TBL] [Abstract][Full Text] [Related]
8. Selective deletion of hepatocyte platelet-derived growth factor receptor α and development of liver fibrosis in mice.
Lim BJ; Lee WK; Lee HW; Lee KS; Kim JK; Chang HY; Lee JI
Cell Commun Signal; 2018 Dec; 16(1):93. PubMed ID: 30509307
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic targeting of SRC kinase in myofibroblast differentiation and pulmonary fibrosis.
Hu M; Che P; Han X; Cai GQ; Liu G; Antony V; Luckhardt T; Siegal GP; Zhou Y; Liu RM; Desai LP; O'Reilly PJ; Thannickal VJ; Ding Q
J Pharmacol Exp Ther; 2014 Oct; 351(1):87-95. PubMed ID: 25047515
[TBL] [Abstract][Full Text] [Related]
10. Ampelopsin attenuates carbon tetrachloride-induced mouse liver fibrosis and hepatic stellate cell activation associated with the SIRT1/TGF-β1/Smad3 and autophagy pathway.
Ma JQ; Sun YZ; Ming QL; Tian ZK; Yang HX; Liu CM
Int Immunopharmacol; 2019 Dec; 77():105984. PubMed ID: 31677501
[TBL] [Abstract][Full Text] [Related]
11. Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress.
Yang JH; Kim SC; Kim KM; Jang CH; Cho SS; Kim SJ; Ku SK; Cho IJ; Ki SH
Eur J Pharmacol; 2016 Jul; 783():92-102. PubMed ID: 27151496
[TBL] [Abstract][Full Text] [Related]
12. Sauchinone attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway.
Lee JH; Jang EJ; Seo HL; Ku SK; Lee JR; Shin SS; Park SD; Kim SC; Kim YW
Chem Biol Interact; 2014 Dec; 224():58-67. PubMed ID: 25451574
[TBL] [Abstract][Full Text] [Related]
13. Profibrogenic transforming growth factor-beta/activin receptor-like kinase 5 signaling via connective tissue growth factor expression in hepatocytes.
Weng HL; Ciuclan L; Liu Y; Hamzavi J; Godoy P; Gaitantzi H; Kanzler S; Heuchel R; Ueberham U; Gebhardt R; Breitkopf K; Dooley S
Hepatology; 2007 Oct; 46(4):1257-70. PubMed ID: 17657819
[TBL] [Abstract][Full Text] [Related]
14. Fyn deficiency attenuates renal fibrosis by inhibition of phospho-STAT3.
Seo HY; Jeon JH; Jung YA; Jung GS; Lee EJ; Choi YK; Park KG; Choe MS; Jang BK; Kim MK; Lee IK
Kidney Int; 2016 Dec; 90(6):1285-1297. PubMed ID: 27616741
[TBL] [Abstract][Full Text] [Related]
15. Cellular crosstalk mediated by platelet-derived growth factor BB and transforming growth factor β during hepatic injury activates hepatic stellate cells.
Mekala S; Tulimilli SV; Geesala R; Manupati K; Dhoke NR; Das A
Can J Physiol Pharmacol; 2018 Aug; 96(8):728-741. PubMed ID: 29558627
[TBL] [Abstract][Full Text] [Related]
16. Heparin-binding epidermal growth factor-like growth factor suppresses experimental liver fibrosis in mice.
Huang G; Besner GE; Brigstock DR
Lab Invest; 2012 May; 92(5):703-12. PubMed ID: 22330337
[TBL] [Abstract][Full Text] [Related]
17. Enhancer of Zeste Homologue 2 Inhibition Attenuates TGF-β Dependent Hepatic Stellate Cell Activation and Liver Fibrosis.
Martin-Mateos R; De Assuncao TM; Arab JP; Jalan-Sakrikar N; Yaqoob U; Greuter T; Verma VK; Mathison AJ; Cao S; Lomberk G; Mathurin P; Urrutia R; Huebert RC; Shah VH
Cell Mol Gastroenterol Hepatol; 2019; 7(1):197-209. PubMed ID: 30539787
[TBL] [Abstract][Full Text] [Related]
18. Rev-erb agonist and TGF-β similarly affect autophagy but differentially regulate hepatic stellate cell fibrogenic phenotype.
Thomes PG; Brandon-Warner E; Li T; Donohue TM; Schrum LW
Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):137-147. PubMed ID: 27840152
[TBL] [Abstract][Full Text] [Related]
19. Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells.
Zhang Z; Yao Z; Wang L; Ding H; Shao J; Chen A; Zhang F; Zheng S
Autophagy; 2018; 14(12):2083-2103. PubMed ID: 30081711
[TBL] [Abstract][Full Text] [Related]
20. The HLF/IL-6/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis.
Xiang DM; Sun W; Ning BF; Zhou TF; Li XF; Zhong W; Cheng Z; Xia MY; Wang X; Deng X; Wang W; Li HY; Cui XL; Li SC; Wu B; Xie WF; Wang HY; Ding J
Gut; 2018 Sep; 67(9):1704-1715. PubMed ID: 28754776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
